TEAD4 and in situ carcinoma: To assess the role of TEAD4 in BLCA, we interrogated a BLCA TMA to determine its expression in this cancer and the association of its expression with patient survival, tumor grade (Low grade, High grade), tumor stage (stage I-IV), T stage (carcinoma in situ [Tis], Ta, T1–T4) and N stage (N0, N1).